| Name | methyl 5-chloro-2-methylpyrazole-3-carboxylate |
|---|---|
| Synonyms | methyl 3-chloro-1-methyl-1h-pyrazole-5-carboxylate |
| Molecular Formula | C6H7ClN2O2 |
|---|---|
| Molecular Weight | 174.58500 |
| Exact Mass | 174.02000 |
| PSA | 44.12000 |
| LogP | 0.86010 |
| HS Code | 2933199090 |
|---|
|
~28%
173841-06-0 |
| Literature: NOVARTIS AG Patent: US2012/258973 A1, 2012 ; Location in patent: Page/Page column 52 ; |
|
~%
173841-06-0 |
| Literature: NOVARTIS AG; BADIGER, Sangamesch; BEHNKE, Dirk; BETSCHART, Claudia; CHAUDHARI, Vinod; CHEBROLU, Murali; COSTESTA, Simona; HINTERMANN, Samuel; MEYER, Arndt; PANDIT, Chetan Patent: WO2011/76744 A1, 2011 ; WO 2011/076744 A1 |
|
~%
173841-06-0 |
| Literature: NOVARTIS AG; BADIGER, Sangamesch; BEHNKE, Dirk; BETSCHART, Claudia; CHAUDHARI, Vinod; CHEBROLU, Murali; COSTESTA, Simona; HINTERMANN, Samuel; MEYER, Arndt; PANDIT, Chetan Patent: WO2011/76744 A1, 2011 ; WO 2011/076744 A1 |
| HS Code | 2933199090 |
|---|---|
| Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |